Sea sponge drug could boost advanced breast cancer survival by 5 extra months

(Cancer Research UK) The cancer drug eribulin, originally developed from sea sponges, could give women with advanced triple negative breast cancer an average of five extra months of life, according to research presented at the National Cancer Research Institute Cancer Conference in Liverpool Monday.